Rashid, Masturah Bte Mohd Abdul <br/><br/>
Optimizing drug combinations against multiple myeloma using a quadratic phenotypic optimization platform (QPOP).  [electronic resource] 

 -  Science translational medicine  08 2018 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1946-6242 
<br/><br/><label>Standard No.: </label>10.1126/scitranslmed.aan0941  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Bortezomib--pharmacology<br/>Cell Line, Tumor<br/>Cyclin-Dependent Kinase Inhibitor p21--genetics<br/>DNA Damage<br/>DNA Methylation--genetics<br/>Decitabine--pharmacology<br/>Dose-Response Relationship, Drug<br/>Drug Resistance, Neoplasm--drug effects<br/>Drug Synergism<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Genes, Tumor Suppressor<br/>High-Throughput Screening Assays<br/>Humans<br/>Mice<br/>Mitomycin--pharmacology<br/>Multiple Myeloma--drug therapy<br/>Phenotype<br/>Protein Tyrosine Phosphatase, Non-Receptor Type 6--genetics<br/>RNA, Messenger--genetics<br/>Tumor Burden--drug effects